Literature DB >> 22082363

Antagonists of LRP6 regulate PTH-induced cAMP generation.

Chenhui Shi1, Jun Li, Weishan Wang, Weiwei Cao, Xu Cao, Mei Wan.   

Abstract

LRP6 is a common coreceoptor for different G protein-coupled seven-transmembrane receptors in production of cAMP. Extracelluar proteins sclerostin and DKK1, initially identified as antagonists for Wnt signaling by binding to LRP6, are negative regulators for bone formation. Here, we show that both sclerostin and DKK1 inhibit PTH-stimulated cAMP production. In addition, PTH suppresses expression of sclerostin in osteocytes in mice. We also found that sclerostin and DKK1 binds to LRP6 as antagonists to increase the availability of LRP6 to facilitate PTH signaling in a positive-feedback fashion. These studies reveal a previously unrecognized function of sclerostin and DKK1, which provides an alternative explanation for the application of sclerostin and DKK1 neutralization on enhancing bone formation as a potential therapy for skeletal diseases.
© 2011 New York Academy of Sciences.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22082363     DOI: 10.1111/j.1749-6632.2011.06226.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  6 in total

1.  Lipoprotein receptor-related protein 6 is required for parathyroid hormone-induced Sost suppression.

Authors:  Changjun Li; Weishan Wang; Liang Xie; Xianghang Luo; Xu Cao; Mei Wan
Journal:  Ann N Y Acad Sci       Date:  2015-04-02       Impact factor: 5.691

2.  Parathyroid hormone-related protein activates Wnt signaling to specify the embryonic mammary mesenchyme.

Authors:  Minoti Hiremath; Pamela Dann; Jennifer Fischer; Daniela Butterworth; Kata Boras-Granic; Julie Hens; Joshua Van Houten; Wei Shi; John Wysolmerski
Journal:  Development       Date:  2012-10-03       Impact factor: 6.868

3.  Parathyroid hormone induces differentiation of mesenchymal stromal/stem cells by enhancing bone morphogenetic protein signaling.

Authors:  Bing Yu; Xiaoli Zhao; Chaozhe Yang; Janet Crane; Lingling Xian; William Lu; Mei Wan; Xu Cao
Journal:  J Bone Miner Res       Date:  2012-09       Impact factor: 6.741

4.  LRP6 in mesenchymal stem cells is required for bone formation during bone growth and bone remodeling.

Authors:  Changjun Li; Bart O Williams; Xu Cao; Mei Wan
Journal:  Bone Res       Date:  2014-04-29       Impact factor: 13.567

5.  Parathyroid hormone 1-34 and skeletal anabolic action: The use of parathyroid hormone in bone formation.

Authors:  L Osagie-Clouard; A Sanghani; M Coathup; T Briggs; M Bostrom; G Blunn
Journal:  Bone Joint Res       Date:  2017-01       Impact factor: 5.853

6.  The effects of romosozumab combined with active vitamin D3 on fracture healing in ovariectomized rats.

Authors:  Ryota Takase; Yuta Tsubouchi; Takefumi Otsu; Takashi Kataoka; Tatsuya Iwasaki; Masashi Kataoka; Hiroshi Tsumura
Journal:  J Orthop Surg Res       Date:  2022-08-12       Impact factor: 2.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.